What You Should Know:

你应该知道的：

–

–

Pulse Charter Connect (PCC)

脉冲宪章连接（PCC）

has oversubscribed a $2 million seed round to modernize and streamline the way lifesaving organs are transported across the United States.

已经超额认购了 200 万美元的种子轮资金，用于现代化和简化救命器官在美国各地的运输方式。

– The round was co-led by Ivy Ventures and Simplex Ventures, with participation from Cedars Sinai Health Ventures, Belal Badat Ventures, Techstars and strategic angel investors. This new funding brings the Chicago-based startup’s total raised to $3.3 million.

本轮融资由Ivy Ventures和Simplex Ventures共同领投，Cedars Sinai Health Ventures、Belal Badat Ventures、Techstars以及战略天使投资人参与。这笔新资金使这家总部位于芝加哥的初创公司累计融资达到330万美元。

Pulse Charter Connect Secures Funding to Revolutionize Organ Transplant Logistics

脉冲宪章连接获得资金，以彻底改变器官移植物流

Pulse Charter Connect (PCC), often called the “Expedia for Organ Transplants,” has secured capital to scale operations, enhance its proprietary logistics software, and expand its national footprint. PCC’s first-of-its-kind platform increases operational efficiency by seamlessly connecting transplant centers with air and ground fleets, ensuring the safe and efficient transportation of organs and surgical teams..

Pulse Charter Connect（PCC），常被称为“器官移植领域的Expedia”，已获得资金以扩大运营、改进其专有物流软件并扩展其在全国的覆盖范围。PCC首创的平台通过无缝连接移植中心与空中和地面车队，提高了运营效率，确保器官和手术团队的安全高效运输。

Founded in 2022 by Laura Epstein, a former aerospace engineer and ex-FAA, PCC was born out of Epstein’s firsthand observations of inefficiencies during a consulting project at the University of Chicago Booth School of Business, where she pursued her MBA. Drawing on her aviation and logistics background, Epstein developed a technology-driven solution to replace the slow, manual coordination that still dominates organ transport today..

PCC 由前航空航天工程师、前 FAA 成员劳拉·爱泼斯坦于 2022 年创立。在芝加哥大学布斯商学院攻读 MBA 期间，爱泼斯坦在一次咨询项目中亲眼观察到效率低下的问题，从而萌生了创立 PCC 的想法。基于其在航空和物流领域的背景，爱泼斯坦开发了一种技术驱动的解决方案，以取代如今仍然主导器官运输的缓慢而手动的协调方式。

The urgency of PCC’s mission is clear: each day, 17 people die waiting for a transplant. While approximately 45,000 organ transplants are performed annually in the U.S., more than 100,000 patients remain on the national waitlist. PCC addresses this gap by streamlining scheduling, optimizing routing, enabling real-time tracking, and ensuring clear communication among donor hospitals, transplant centers, and transport partners..

PCC使命的紧迫性显而易见：每天有17人因等待移植而死亡。尽管美国每年大约进行45,000例器官移植手术，但仍有超过10万名患者在全国等待名单上。PCC通过简化调度、优化路线、实现实时追踪以及确保捐赠医院、移植中心和运输伙伴之间的清晰沟通来弥补这一差距。

Since launching in April 2024, Pulse Charter Connect has already facilitated organ transports that saved over 65 lives across the Midwest and Mid-Atlantic regions. The startup is a graduate of Techstars, Tampa Bay Wave, and Cedars Sinai Accelerator, and has earned multiple awards and top placements at U.S.

自 2024 年 4 月推出以来，Pulse Charter Connect 已经促成了挽救中西部和大西洋中部地区超过 65 条生命的器官运输。这家初创公司是 Techstars、Tampa Bay Wave 和 Cedars Sinai Accelerator 的毕业生，并在美国获得了多个奖项和顶尖排名。

pitch competitions..

商业计划竞赛..

Scott Kraege, Managing Partner at Ivy Ventures, praised PCC’s mission, noting, “Laura and the Pulse team are tackling one of the most pressing challenges in healthcare logistics—with the speed, precision, and transparency that should be mandatory.”

Ivy Ventures的管理合伙人Scott Kraege赞扬了PCC的使命，他指出：“Laura和Pulse团队正在应对医疗物流领域最紧迫的挑战之一——其速度、精度和透明度应该成为标配。”